Search results for "hiv-1 protease"

showing 5 items of 5 documents

Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors

2021

The approval of the first HIV-1 protease inhibitors (HIV-1 PRIs) marked a fundamental step in the control of AIDS, and this class of agents still represents the mainstay therapy for this illness. Despite the undisputed benefits, the necessary lifelong treatment led to numerous severe side-effects (metabolic syndrome, hepatotoxicity, diabetes, etc.). The HIV-1 PRIs are capable of interacting with “secondary” targets (off-targets) characterized by different biological activities from that of HIV-1 protease. In this scenario, the in-silico techniques undoubtedly contributed to the design of new small molecules with well-fitting selectivity against the main target, analyzing possible undesirabl…

0301 basic medicineon/off-targetsProtein ConformationComputer sciencemedicine.medical_treatmentHIV InfectionsLigands01 natural sciencesHIV ProteaseHIV-1 proteaseCatalytic DomainDrug DiscoveryBiology (General)DRUDITSpectroscopyMolecular StructurebiologyGeneral MedicineResearch processSmall moleculeComputer Science ApplicationsMolecular Docking SimulationChemistryligand-structure basedQH301-705.5NCI databaseComputational biologyArticleCatalysisInorganic ChemistryStructure-Activity Relationshipmolecular descriptors03 medical and health sciencesHIV-1 proteasemedicineHumansComputer SimulationPhysical and Theoretical ChemistryQD1-999Molecular BiologyVirtual screeningProteaseOrganic ChemistryHIV Protease Inhibitorsmolecular dockingvirtual screening0104 chemical sciences010404 medicinal & biomolecular chemistry030104 developmental biologyDrug DesignHIV-1biology.proteinInternational Journal of Molecular Sciences
researchProduct

Computational methodologies in the discovery of inhibitors of HIV-1

2009

HIV-1 reverse trascriptaseHIV-1 proteasedockingpharmacophore modelingmultivariate analysiSettore CHIM/08 - Chimica FarmaceuticaHIV-1 inhibitor
researchProduct

Molecular dynamics studies on HIV-1 protease: a comparison of the flap motions between wild type protease and the M46I/G51D double mutant

2007

The emergence of drug-resistant mutants of HIV-1 is a tragic effect associated with conventional long-treatment therapies against acquired immunodeficiency syndrome. These mutations frequently involve the aspartic protease encoded by the virus; knowledge of the molecular mechanisms underlying the conformational changes of HIV-1 protease mutants may be useful in developing more effective and longer lasting treatment regimes. The flap regions of the protease are the target of a particular type of mutations occurring far from the active site. These mutations modify the affinity for both substrate and ligands, thus conferring resistance. In this work, molecular dynamics simulations were perform…

Models MolecularGromacs 3.2Anti-HIV AgentsProtein Conformationmedicine.medical_treatmentflap motionMutantCatalysisVirusInorganic ChemistryProtein structureHIV ProteaseHIV-1 proteaseDrug Resistance ViralEnzyme StabilityHIV-1 proteasemedicineHumansComputer SimulationPhysical and Theoretical Chemistrychemistry.chemical_classificationProteasebiologyHIV-1 drug-resistant mutantOrganic ChemistryWild typeActive siteRecombinant ProteinsComputer Science ApplicationsCell biologyEnzymemolecular dynamics simulationAmino Acid SubstitutionComputational Theory and MathematicsBiochemistrychemistryMutationHIV-1biology.protein
researchProduct

A Multivariate Analysis of HIV-1 Protease Inhibitors and Resistance Induced by Mutation

2005

This paper describes the use of the multivariate statistical procedure principal component analysis as a tool to explore the inhibitory activity of classes of protease inhibitors (PIs) against HIV-1 viruses (wild type and more-frequent single mutants, V82A, V82F, and I84V) and against protease enzymes. The analysis of correlations between biological activity and molecular descriptors or similarity indexes allowed a reliable classification of the 51 derivatives considered in this study. The best results were obtained in the case of the I84V mutant for which a high number of predictions was achieved. On this basis, this statistical approach is proposed as a reliable method for the prediction …

STRUCTURE-BASED DESIGNMultivariate analysisGeneral Chemical Engineeringmedicine.medical_treatmentMutantComputational biologyLibrary and Information SciencesModels BiologicalStructure-Activity RelationshipHIV-1 proteaseMolecular descriptorDrug Resistance ViralmedicineHIV Protease InhibitorBIOLOGICAL EVALUATIONGeneticschemistry.chemical_classificationProteasebiologyWild typeBiological activityANTIVIRAL ACTIVITYGeneral ChemistryHIV Protease InhibitorsGeneral MedicineD-AMINO ACIDSIN-VITROComputer Science ApplicationsORALLY BIOAVAILABLE INHIBITOREnzymechemistryRAY CRYSTAL-STRUCTUREMultivariate AnalysisMutationHUMAN-IMMUNODEFICIENCY-VIRUSHIV-1biology.proteinTYPE-1 PROTEASEQUANTITATIVE STRUCTURESoftware
researchProduct

[60]Fullerene l -Amino Acids and Peptides: Synthesis under Phase-Transfer Catalysis Using a Phosphine–Borane Linker. Electrochemical Behavior

2017

International audience; A new method to link amino acid and peptide derivatives to [60]fullerene is described. It uses hydrophosphination with a secondary phosphine borane. First, the stereoselective synthesis of secondary phosphine borane amino acid derivatives was achieved by alkylation of phenylphosphine borane with gamma-iodo-alpha-amino ester reagents under phase transfer catalysis (PTC). Second, a sec-phosphine borane amino ester was saponified and coupled with alpha,gamma-diamino esters to afford the corresponding dipeptide derivatives in good yields. Finally, the hydrophosphination reaction of [60]fullerene by the sec-phosphine borane compounds was performed under PTC to obtain C-60…

p-chiral phosphiniteshiv-1 proteaseBoraneAlkylation010402 general chemistrychemistry01 natural scienceschemistry.chemical_compoundc60[ CHIM.ORGA ] Chemical Sciences/Organic chemistryredox propertiesOrganic chemistrytertiary phosphinesRacemizationchemistry.chemical_classificationAddition reactionbond activationDipeptide010405 organic chemistry[CHIM.ORGA]Chemical Sciences/Organic chemistryOrganic ChemistrybuckminsterfullereneCombinatorial chemistryfullerene c-600104 chemical sciencesAmino acidchemistryPhenylphosphinederivativesPhosphine
researchProduct